Ozempic-like weight loss drugs may help the heart recover after a heart attack

What Is Food Noise? The Science Behind GLP-1s and Quiet Minds

Article

Ada — Gila·3/9/2026

What Is Food Noise? The Science Behind GLP-1s and Quiet Minds

Food noise is the constant, intrusive mental chatter about food that millions experience daily. This deep dive explains the neuroscience of how GLP-1 medications like semaglutide and tirzepatide quiet food noise by modulating the hypothalamus and reward pathways, distinguishes food noise from physiological hunger, and provides three evidence-based strategies — trigger-food visibility friction, small-plate pacing, and anchor meal templates — for managing it. Backed by research from JAMA, Cleveland Clinic, and NHS guidance.

Why 53.6% of GLP-1 Users Quit Within a Year (And How to Be in the Other Half)

A JAMA Network Open study of 125,474 adults found that 53.6% discontinue GLP-1 medications within one year. This evidence-based analysis examines the six key reasons — side effects, cost, supply shortages, unrealistic expectations, premature cessation, and lack of support structure — and provides clinically-grounded strategies for staying on track, including the Weekly Plateau Scoreboard, Rebound Early-Warning Threshold, and structured side effect management. Anchored by STEP 4 trial data showing 14.8 percentage points difference between continuing and stopping.

Oral GLP-1 Pills 2026: Wegovy, Foundayo, and Orforglipron Compared

Three oral GLP-1s now have FDA approval: Wegovy pill ($675/mo, Dec 2025), Foundayo orforglipron ($149/mo, April 2026), and Rybelsus (off-label). Trial data shows oral matches injection efficacy within 1-3pp. Here is the full comparison: efficacy, dose timing, side effects, cost.

Ozempic-like weight loss drugs may help the heart recover after a heart attack

Ready to start your GLP-1 journey?

Related Articles

What Is Food Noise? The Science Behind GLP-1s and Quiet Minds

Why 53.6% of GLP-1 Users Quit Within a Year (And How to Be in the Other Half)

Oral GLP-1 Pills 2026: Wegovy, Foundayo, and Orforglipron Compared